Drug induced interstitial lung disease
- PMID: 22896776
- PMCID: PMC3415629
- DOI: 10.2174/1874306401206010063
Drug induced interstitial lung disease
Abstract
With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents. There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease. Other causes of ILD must be excluded. Treatment is avoidance of further exposure and systemic corticosteroids in patients with progressive or disabling disease.
Keywords: Lung; adverse drug reaction; diagnosis; drug-induced lung disease; mechanism of pulmonary toxicity; review.; treatment.
Figures
References
-
- Camus P, Rosenow E. Latrogenic lung disease. Clin Chest Med. 2004;25:xiii–xix. - PubMed
-
- Flieder D, Travis W. Pathologic characteristics of drug-induced lung disease. Clin Chest Med. 2004;25:37–45. - PubMed
-
- Nemery B, Bast A, Behr J, et al. Interstitial lung disease induced by exogenous agents: factors governing susceptibility. Eur Respir J . 2001;18:30S –42S. - PubMed
-
- Spear B, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med. 2002;7:201–4. - PubMed
-
- Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources